Ocular Therapeutix Inc (OCUL)
6.17
+0.30
(+5.11%)
USD |
NASDAQ |
May 03, 16:00
6.16
-0.01
(-0.16%)
After-Hours: 20:00
Ocular Therapeutix Free Cash Flow: -76.32M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -76.32M |
| September 30, 2023 | -72.52M |
| June 30, 2023 | -78.49M |
| March 31, 2023 | -67.79M |
| December 31, 2022 | -63.32M |
| September 30, 2022 | -59.99M |
| June 30, 2022 | -59.29M |
| March 31, 2022 | -68.10M |
| December 31, 2021 | -66.74M |
| September 30, 2021 | -57.46M |
| June 30, 2021 | -58.07M |
| March 31, 2021 | -52.81M |
| December 31, 2020 | -54.40M |
| September 30, 2020 | -67.96M |
| June 30, 2020 | -74.06M |
| March 31, 2020 | -78.81M |
| December 31, 2019 | -79.82M |
| September 30, 2019 | -73.88M |
| June 30, 2019 | -65.26M |
| March 31, 2019 | -58.37M |
| December 31, 2018 | -51.12M |
| Date | Value |
|---|---|
| September 30, 2018 | -47.94M |
| June 30, 2018 | -53.01M |
| March 31, 2018 | -55.35M |
| December 31, 2017 | -58.72M |
| September 30, 2017 | -56.07M |
| June 30, 2017 | -47.85M |
| March 31, 2017 | -42.77M |
| December 31, 2016 | -35.92M |
| September 30, 2016 | -36.74M |
| June 30, 2016 | -38.31M |
| March 31, 2016 | -37.67M |
| December 31, 2015 | -35.52M |
| September 30, 2015 | -32.48M |
| June 30, 2015 | -29.31M |
| March 31, 2015 | -24.67M |
| December 31, 2014 | -21.76M |
| September 30, 2014 | -19.35M |
| June 30, 2014 | -15.70M |
| March 31, 2014 | -13.96M |
| December 31, 2013 | -13.03M |
Free Cash Flow Range, Past 5 Years
-79.82M
Minimum
Dec 2019
-52.81M
Maximum
Mar 2021
-67.11M
Average
-67.79M
Median
Mar 2023
Free Cash Flow Benchmarks
| Amgen Inc | 7.098B |
| Assertio Holdings Inc | 48.98M |
| CytomX Therapeutics Inc | -56.88M |
| EyePoint Pharmaceuticals Inc | -1.608M |
| Regeneron Pharmaceuticals Inc | 3.930B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.45M |
| Cash from Investing (Quarterly) | -0.459M |
| Cash from Financing (Quarterly) | 108.17M |
| Free Cash Flow Per Share (Quarterly) | -0.2539 |
| Free Cash Flow to Equity (Quarterly) | -23.95M |
| Free Cash Flow Yield | -14.96% |